首页> 外文OA文献 >Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients

【2h】

Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients

机译：验证12-基因结肠癌复发评分作为阶段II和III直肠癌患者的复发风险的预测因子

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Marlies S. Reimers; Peter J. K. Kuppen; Mark Lee; Margarita Lopatin; Haluk Tezcan; Hein Putter; Kim Clark-Langone; Gerrit Jan Liefers; Steve Shak; Cornelis J. H. van de Velde;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and II Rectal Cancer Patients [J] . Reimers Marlies S., Kuppen Peter J. K., Lee Mark, Journal of the National Cancer Institute . 2014,第11期

机译：验证12基因结肠癌复发评分作为II和II期直肠癌患者复发风险的预测因子
2. Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and II Rectal Cancer Patients [J] . Reimers Marlies S., Kuppen Peter J. K., Lee Mark, Journal of the National Cancer Institute . 2014,第11期

机译：验证12-基因结肠癌复发评分作为阶段II和II直肠癌患者的复发风险的预测因子
3. Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin [J] . Greg Yothers, Michael J. OConnell, Mark Lee, Journal of Clinical Oncology . 2013,第36期

机译：验证NSABP C-07中的12基因结肠癌复发评分可作为氟尿嘧啶和白三叶素（FU / LV）和FU / LV加奥沙利铂治疗的II期和III期结肠癌患者复发的预测指标
4. Potential usefulness of a topic model-based categorization of lung cancers as quantitative CT biomarkers for predicting the recurrence risk after curative resection [C] . Y. Kawata, N. Niki, H. Ohmatsu, Conference on computer-aided diagnosis . 2014

机译：基于主题模型的肺癌分类作为定量CT生物标记物对预测根治性切除术后复发风险的潜在作用
5. The Association of Hospital and Patient Characteristics with Treatment Initiation among Veterans with Stage I, II, or III Lung, Colon or Rectal Cancer [D] . Clary, Alecia S. 2019

机译：具有阶段I，II或III肺，结肠或直肠癌的退伍军人治疗发起的医院和患者特征
6. Validation of the 12-Gene Colon Cancer Recurrence Score in NSABP C-07 As a Predictor of Recurrence in Patients With Stage II and III Colon Cancer Treated With Fluorouracil and Leucovorin (FU/LV) and FU/LV Plus Oxaliplatin [O] . Greg Yothers, Michael J. OConnell, Mark Lee, -1

机译：验证NSABP C-07中的12基因结肠癌复发评分可作为氟尿嘧啶和白三叶素（FU / LV）和FU / LV加奥沙利铂治疗的II期和III期结肠癌患者复发的预测因子
7. Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer [O] . 2014

机译：预测II期结肠癌复发风险的12基因分析的比较经济学

Validation of the 12-Gene Colon Cancer Recurrence Score as a Predictor of Recurrence Risk in Stage II and III Rectal Cancer Patients

著录项

引文网络

相似文献

相关主题

期刊订阅